Literature DB >> 28993351

Haematuria in ADPKD: not always benign. Be aware!

Manav Agarwal1, Ashok Kumar Sokhal1, Manoj Kumar1, Sunny Goel1.   

Abstract

Haematuria in patients with autosomal dominant polycystic kidney disease (ADPKD) is a very common manifestation. The cause of haematuria is often benign with the most common cause being haemorrhage within the renal cyst. But haematuria may also be caused by a coincident malignancy, the diagnosis of which may be missed if not investigated thoroughly. Herein, we present a case of ADPKD who presented to us with haematuria and was later found to have bladder cancer. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  chronic renal failure; renal system; urinary and genital tract disorders; urological cancer

Mesh:

Year:  2017        PMID: 28993351      PMCID: PMC5652374          DOI: 10.1136/bcr-2017-220638

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Lesson of the week: Causes of haematuria in adult polycystic kidney disease.

Authors:  R Dedi; S Bhandari; J H Turney; A M Brownjohn; I Eardley
Journal:  BMJ       Date:  2001-08-18

2.  Patient-specific risk of undetected malignant disease after investigation for haematuria, based on a 4-year follow-up.

Authors:  Thomas J Edwards; Andrew J Dickinson; Jane Gosling; Paul D McInerney; Salvatore Natale; John S McGrath
Journal:  BJU Int       Date:  2010-08-19       Impact factor: 5.588

3.  Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria.

Authors:  Ramón Peces; Ana Aguilar; Cristina Vega; Emilio Cuesta; Carlos Peces; Rafael Selgas
Journal:  Nefrologia       Date:  2012-02-04       Impact factor: 2.033

4.  Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Arlene B Chapman; Olivier Devuyst; Kai-Uwe Eckardt; Ron T Gansevoort; Tess Harris; Shigeo Horie; Bertram L Kasiske; Dwight Odland; York Pei; Ronald D Perrone; Yves Pirson; Robert W Schrier; Roser Torra; Vicente E Torres; Terry Watnick; David C Wheeler
Journal:  Kidney Int       Date:  2015-03-18       Impact factor: 10.612

Review 5.  Autosomal dominant polycystic kidney disease.

Authors:  P A Gabow
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

6.  Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria.

Authors:  Tatsuya Suwabe; Yoshifumi Ubara; Keiichi Sumida; Noriko Hayami; Rikako Hiramatsu; Masayuki Yamanouchi; Eiko Hasegawa; Junichi Hoshino; Naoki Sawa; Satoshi Saitoh; Itsuko Okuda; Kenmei Takaichi
Journal:  Clin Exp Nephrol       Date:  2012-06-13       Impact factor: 2.801

7.  Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens.

Authors:  Cordula A Jilg; Vanessa Drendel; Janina Bacher; Przemyslaw Pisarski; Hannes Neeff; Oliver Drognitz; Malte Schwardt; Sven Gläsker; Angelica Malinoc; Zoran Erlic; Mercedes Nunez; Alexander Weber; Pablo Azurmendi; Wolfgang Schultze-Seemann; Martin Werner; Hartmut P H Neumann
Journal:  Nephron Clin Pract       Date:  2013-06-04

Review 8.  Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2016.

Authors:  Fouad T Chebib; Vicente E Torres
Journal:  Am J Kidney Dis       Date:  2015-10-31       Impact factor: 8.860

Review 9.  The association between symptoms and bladder or renal tract cancer in primary care: a systematic review.

Authors:  Mia Schmidt-Hansen; Sabine Berendse; William Hamilton
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.